[Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula]

Zhonghua Zhong Liu Za Zhi. 2024 Mar 23;46(3):263-268. doi: 10.3760/cma.j.cn112152-20231024-00219.
[Article in Chinese]

Abstract

Objective: To explore the causes and therapeutic effects of pelvic pain caused by rectal fistula or bladder fistula after comprehensive treatment of cervical cancer and rectal cancer (radiotherapy, surgery, chemotherapy, and other treatments). Methods: A retrospective analysis was conducted on the clinical and pathological data of patients with pelvic tumors admitted to the First People's Hospital of Yinchuan City, Ningxia and the Affiliated Cancer Hospital of Zhengzhou University from June 2016 to June 2022. The causes of persistent pelvic pain in patients after comprehensive treatment was investigated, and the corresponding therapeutic effects after clinical treatment was observed. Results: Thirty-two tumor patients experienced persistent pain after comprehensive treatment, including 22 cases of cervical cancer and 10 cases of rectal cancer. The preoperative pain of the entire group of patients was evaluated using the digital grading method, with a pain score of (7.88±1.31) points. Among the 32 patients, there were 16 cases of rectovaginal fistula or ileovaginal fistula, 9 cases of vesicovaginal fistula, 5 cases of rectoperineal fistula, and 2 cases of vesicovaginorectal fistula. Thirty-two patients were initially treated with medication to relieve pain, and according to the ruptured organs, a fistula was made to the corresponding proximal intestinal canal and renal pelvis to intercept the intestinal contents and urine. However, the pain did not significantly be improved. The pain score of treatment with the above methods for one week was (8.13±1.13) points, and there was no statistically significant difference compared to preoperative treatment (P=0.417). In the later stage, based on a comprehensive evaluation of whether the tumor had recurred, the value of organ preservation, the benefits of surgery, the balance between survival time and improving quality of life, pathological organ resection or repair was performed. The surgical methods included repair of leaks, local debridement combined with irrigation of proximal intestinal fluid, distal closure of the sigmoid colon combined with proximal ostomy, posterior pelvic organ resection, anterior pelvic organ resection, and total pelvic organ resection. One week after surgery, the patients' pain completely relieved or disappeared, with the pain score of (1.72±1.37) points, which was significantly divergent from the preoperative and initial surgical treatments (P<0.001). Conclusions: Palliative pyelostomy and proximal enterostomy cannot effectively alleviate persistent pelvic floor pain. The fundamental way to alleviate pain is complete blocking of the inflammatory erosion of the intestinal fluid and urine.

目的: 探讨宫颈癌、直肠癌综合治疗(放疗、手术、化疗及其他治疗)后出现直肠瘘、膀胱瘘导致盆部顽固疼痛的治疗方法及疗效。 方法: 回顾性分析2016年6月至2022年6月银川市第一人民医院和郑州大学附属肿瘤医院收治盆腔疼痛患者的临床病理资料,探讨患者综合治疗后出现盆部顽固疼痛的原因,观察临床治疗后相应的疗效。 结果: 32例肿瘤患者综合治疗后出现盆部顽固性疼痛,其中宫颈癌22例,直肠癌10例。全组患者术前疼痛评分为(7.88±1.31)分。32例患者中,直肠阴道瘘或回肠阴道瘘16例,膀胱阴道瘘9例,直肠会阴瘘5例,膀胱阴道直肠瘘2例。32例患者初期给予药物止痛治疗,并根据溃破脏器行相应的近端肠管及肾盂造瘘,截留肠内容物及尿液,疼痛未明显缓解,以上方式治疗1周疼痛评分为(8.13±1.13)分,与术前相比,差异无统计学意义(P=0.417)。后期根据肿瘤是否复发、脏器是否有保留价值、手术是否受益、生存时间与提高生活质量权衡等综合评判,行病变脏器切除或修补,手术方式包括瘘口的修补、局部清创+近端肠液截留冲洗、乙状结肠远端闭合+近端造瘘术、后盆腔脏器切除、前盆腔脏器切除和全盆腔脏器切除术,术后1周患者疼痛完全缓解或消失,疼痛评分为(1.72±1.37)分,与术前、初期手术之治疗前比较差异均有统计学意义(均P<0.001)。 结论: 姑息性肾盂造瘘及近端肠管造瘘不能有效缓解盆底顽固性疼痛,缓解疼痛的根本方法为彻底阻断肠液、尿液的感染。.

Publication types

  • English Abstract

MeSH terms

  • Female
  • Humans
  • Pelvic Pain / drug therapy
  • Pelvic Pain / etiology
  • Quality of Life
  • Rectal Neoplasms* / complications
  • Rectal Neoplasms* / drug therapy
  • Rectal Neoplasms* / surgery
  • Retrospective Studies
  • Treatment Outcome
  • Urinary Bladder / pathology
  • Uterine Cervical Neoplasms* / complications
  • Uterine Cervical Neoplasms* / pathology